概括
合成多抗原诱导了子的免疫不响应. 这种免疫耐受性是特异性的,因为动物仍然对像卵素这样的无关抗原有反应.
科学领域:
- 免疫学 免疫学 免疫学
- 实验医学是一种实验医学.
背景情况:
- 免疫学耐受性对于预防自身免疫性疾病至关重要.
- 了解耐受性诱导的机制是开发新免疫疗法的关键.
研究的目的:
- 为了研究使用合成多抗原诱导免疫耐受性.
- 为了确定诱导免疫不响应的特异性.
主要方法:
- 成年子接受了6 - 默卡普托普林的治疗,并注射了合成多抗原.
- 新生子被注射了同样的合成多抗原.
- 随后进行免疫接种以评估免疫反应.
- 对非相关抗原 (卵泡蛋白) 的反应性在耐受性动物中进行了测试.
主要成果:
- 接受6 - 默卡托普林治疗的子或新生子对合成多抗原产生了免疫不响应.
- 诱导的耐受性是特定的,因为动物对卵素没有表现出不反应.
结论:
- 合成多抗原可以在子中诱导特定的免疫耐受性.
- 该模型提供了关于免疫耐受性诱导机制及其潜在应用的见解.
相关概念视频
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Cross-reactivity
Overview
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...


